Order Article Reprints

Sousa G, de Almeida MCF, Lócio LL, dos Santos VL, Bezerra DP, Silva VR, de Almeida SMV, Simon A, Honório TdS, Cabral LM, et al. Synthesis and Evaluation of Antiproliferative Activity, Topoisomerase IIα Inhibition, DNA Binding and Non-Clinical Toxicity of New Acridine–Thiosemicarbazone Derivatives. Pharmaceuticals. 2022; 15(9):1098. https://doi.org/10.3390/ph15091098

Sousa, Gleyton, Maria C. F. de Almeida, Lucas L. Lócio, Vanda L. dos Santos, Daniel P. Bezerra, Valdenizia R. Silva, Sinara M. V. de Almeida, Alice Simon, Thiago da S. Honório, Lucio M. Cabral, and et al. 2022. "Synthesis and Evaluation of Antiproliferative Activity, Topoisomerase IIα Inhibition, DNA Binding and Non-Clinical Toxicity of New Acridine–Thiosemicarbazone Derivatives" Pharmaceuticals 15, no. 9: 1098. https://doi.org/10.3390/ph15091098

Sousa, G., de Almeida, M. C. F., Lócio, L. L., dos Santos, V. L., Bezerra, D. P., Silva, V. R., de Almeida, S. M. V., Simon, A., Honório, T. d. S., Cabral, L. M., Castro, R. N., de Moura, R. O., & Kümmerle, A. E. (2022). Synthesis and Evaluation of Antiproliferative Activity, Topoisomerase IIα Inhibition, DNA Binding and Non-Clinical Toxicity of New Acridine–Thiosemicarbazone Derivatives. Pharmaceuticals, 15(9), 1098. https://doi.org/10.3390/ph15091098